19 June 2013
Keywords: Cell Therapeutics, Pixuvri, Non-Hodgkin lymphoma, NHL, Launch, Europe
Article | 12 September 2012
Following the European approval of the drug this spring (The Pharma Letter May 14), US biotech firm Cell Therapeutics (Nasdaq and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.